These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5303521)

  • 21. ["Inducing" power of a drug on hepatic pharmacometabolic enzymes and on variations in relation to situations of the organism which can modify the metabolic degradation of the drug itself].
    Chiesara E; Conti F; Fanti A
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1704-8. PubMed ID: 5589092
    [No Abstract]   [Full Text] [Related]  

  • 22. APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES.
    BURNS JJ; CUCINELL SA; KOSTER R; CONNEY AH
    Ann N Y Acad Sci; 1965 Mar; 123():273-86. PubMed ID: 14329210
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo activation of oxidative drug metabolism by flavonoids.
    Lasker JM; Huang MT; Conney AH
    J Pharmacol Exp Ther; 1984 Apr; 229(1):162-70. PubMed ID: 6323685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role of the dietary lipid in the ability of phenobarbital to stimulate drug detoxification.
    Century B
    J Pharmacol Exp Ther; 1973 May; 185(2):185-94. PubMed ID: 4703818
    [No Abstract]   [Full Text] [Related]  

  • 25. Contrastic effects of ethionine and carbontetrachloride on ascorbic acid metabolism and on the activity of microsomal drug-metabolizing enzymes in rats.
    Kato R
    Jpn J Pharmacol; 1967 Mar; 17(1):64-75. PubMed ID: 5299976
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the possibility of transmission to the regenerating liver of pharmacometabolic "induction". I. Time elapsed between the administration of the inducing drug and hepatectomy and maximum enzymatic activity in the newly formed liver].
    Chiesara E; Conti F; Fanti A
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1693-6. PubMed ID: 5589088
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of splenectomy on the activity of drug-metabolizing enzymes in the liver of rats.
    Brodeur J; Marchand C
    Can J Physiol Pharmacol; 1971 Mar; 49(3):161-6. PubMed ID: 5124922
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 29. Alteration of in vivo zoxazolamine metabolism by carbon monoxide in normal and polycyclic hydrocarbon-treated immature male rats.
    Krevsky B; Hitchcock M
    Drug Metab Dispos; 1977; 5(5):451-3. PubMed ID: 20293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of combined treatment with pregnenolone-16alpha-carbonitrile and spironolactone or phenobarbital on drug metabolism in rats.
    Ship S; Kourounakis P
    Biochem Pharmacol; 1977 Mar; 26(6):467-72. PubMed ID: 849342
    [No Abstract]   [Full Text] [Related]  

  • 31. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS.
    KATO R; CHIESARA E; VASSANELLI P
    Biochem Pharmacol; 1964 Jan; 13():69-83. PubMed ID: 14106733
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzymic mechanism of metabolism of the phosphorothionate insecticides.
    Neal RA
    Arch Intern Med; 1971 Jul; 128(1):118-24. PubMed ID: 5088408
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors affecting the toxicity and metabolism of OMPA (octamethylpyrophosphoramide) in rats.
    Kato R; Takanaka A; Omori Y
    Jpn J Pharmacol; 1967 Dec; 17(4):509-18. PubMed ID: 4297568
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the mechanism of phenobarbital-induced protection against malathion and EPN.
    Brodeur J
    Can J Physiol Pharmacol; 1967 Nov; 45(6):1061-9. PubMed ID: 6064053
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin.
    Lubawy WC; Kostenbauder HB; Stavchansky SA
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):75-82. PubMed ID: 4847907
    [No Abstract]   [Full Text] [Related]  

  • 36. Massive liver enlargement accompanied by decreased drug metabolism. Effect of anterior pituitary extract on hepatic ultrastructure, zoxazolamine paralysis, and metabolism in the rat.
    Szabo S; Garg BD; Kourounakis P; Tuchweber B
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1135-42. PubMed ID: 922587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution to the study of the metabolism of zoxazolamine in the rodents].
    Buchel L
    Arch Sci Physiol (Paris); 1971; 25(1):19-45. PubMed ID: 5562527
    [No Abstract]   [Full Text] [Related]  

  • 38. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract]   [Full Text] [Related]  

  • 39. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
    Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo activation of zoxazolamine metabolism by flavone.
    Lasker JM; Huang M-T ; Conney AH
    Science; 1982 Jun; 216(4553):1419-21. PubMed ID: 7089530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.